Clue found to why body resists cancer-killing viruses
June 11th, 2008 - 2:16 pm ICT by IANS
Washington, June 11 (IANS) Viruses designed to treat incurable brain tumours like glioblastoma were stumped by how the immune system eliminated them at the outset. Now an animal study conducted by Ohio State University researchers helps explain why this happened, a development that could help improve therapy for brain cancer patients.
The study shows how viruses that destroy the tumour cells also cause them to throw up proteins stimulating growth of new tumour blood vessels.
These vessels transport immune cells that eradicate the viruses, stimulating tumour re-growth.
“This study points to an important side-effect of oncolytic viral therapy that may limit its efficacy,” said Balveen Kaur, who was part of the research team.
“We can now work on designing a combination therapy that will inhibit this effect and enhance the action of the viral therapy.”
The findings of the study have been published in the latest issue of the journal Molecular Therapy.
- Novel tumour-attacking virus may offer brain cancer treatment - Dec 02, 2009
- Cancer-killing viruses stimulate tumor blood-vessel growth - Jun 11, 2008
- Targeted photodynamic therapy offers hope for skin cancer patients - Apr 12, 2011
- Herbal remedy beats brain cancer - Jul 13, 2011
- Modified measles virus may help treat childhood brain tumours - May 27, 2010
- New procedure busts deadly brain tumour cells - Feb 06, 2012
- Discovery could lead to 'next-gen' vaccines - Apr 08, 2012
- Bad cholesterol feeds brain tumours - Sep 16, 2011
- New process to 'program' cancer cell death created - Sep 08, 2010
- Deadly brain tumour's strength may be a weakness as well - Aug 15, 2010
- Mechanism that helps brain cancer evade immune system attack discovered - Jan 16, 2010
- Cancer drug successfully purges hidden HIV virus - Mar 09, 2012
- New 'nanodrug' can attack breast cancer cells from the inside out - Mar 30, 2011
- Novel method might help block for tumour growth - Mar 15, 2011
- Potential therapeutic target for brain cancer identified - Feb 23, 2010
Tags: animal study, blood vessels, brain cancer patients, brain tumours, clue, combination therapy, efficacy, immune cells, immune system, kaur, ohio state university, outset, proteins, tumour cells, university researchers, viral therapy